✦ LIBER ✦

1959 MIRABEGRON IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME - RESULTS FROM A NORTH-AMERICAN STUDY

✍ Scribed by Nitti, Victor; Herschorn, Sender; Auerbach, Stephen; Martin, Nancy; Blauwet, Mary Beth; Marshall, Thomas

Book ID: 122769133
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 48 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.2163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

885 THE EFFICACY AND SAFETY OF MIRABEGRO

885 THE EFFICACY AND SAFETY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME – RESULTS FROM A NORTH-AMERICAN PHASE III TRIAL

✍ V. Nitti; S. Herschorn; S. Auerbach; M. Ayers; M. Lee; N. Martin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Tolterodine extended release improves pa

Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial

✍ R. ROBERTS; T. BAVENDAM; D. B. GLASSER; M. CARLSSON; N. EYLAND; V. ELINOFF 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

1958 COMBINATION TREATMENT WITH MIRABEGR

1958 COMBINATION TREATMENT WITH MIRABEGRON AND SOLIFENACIN IN PATIENTS WITH OVERACTIVE BLADDER (OAB) - EFFICACY RESULTS FROM A PHASE 2 STUDY (SYMPHONY)

✍ Abrams, Paul; Kelleher, Con; Staskin, David; Kay, Richard; Martina, Reynaldo Vil 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 237 KB

886 THE EFFICACY AND TOLERABILITY OF MIR

886 THE EFFICACY AND TOLERABILITY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER – RESULTS FROM A EUROPEAN–AUSTRALIAN PHASE III TRIAL

✍ V. Khullar; J. Cambronero; P. Ströberg; J. Angulo; P. Boerrigter; M.B. Blauwet; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Combination Treatment with Mirabegron an

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

✍ Abrams, Paul; Kelleher, Con; Staskin, David; Rechberger, Tomasz; Kay, Richard; M 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 688 KB

Efficacy and Tolerability of Mirabegron,

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

✍ Vik Khullar; Gerard Amarenco; Javier C. Angulo; Javier Cambronero; Kjetil Høye; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 827 KB